Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor-derived Infection”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableNot Yet RecruitingNCT07651137
What this trial is testing

Impact of Culture of Perfusion Fluid on Donor-derived Infection Management and Outcome in Liver and Kidney Transplant

Who this might be right for
Liver Transplant InfectionKidney Transplant InfectionLiver Transplant+3 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,400
Testing effectiveness (Phase 2)Study completedNCT01646645
What this trial is testing

Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegalovirus
Memorial Sloan Kettering Cancer Center 58
Early research (Phase 1)UnknownNCT05140187
What this trial is testing

CMV-TCR-T Cells for CMV Infection After Allogenic HSCT

Who this might be right for
CMV Infection After Allogenic HSCT
Chinese PLA General Hospital 12
Very early researchLooking for participantsNCT06793241
What this trial is testing

Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Zhejiang University 15
Very early researchNot Yet RecruitingNCT07476014
What this trial is testing

Early Clinical Study on the Use of Donor-derived EBV-specific T Cells for the Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 18
Early research (Phase 1)Ended earlyNCT03579888
What this trial is testing

CD19-Specific T Cells Post AlloSCT

Who this might be right for
B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A RearrangedRecurrent B Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+14 more
M.D. Anderson Cancer Center 4
Not applicableActive Not RecruitingNCT07015801
What this trial is testing

CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency

Who this might be right for
Cytomegalovirus ViremiaCytomegalovirus PneumoniaT-Lymphocyte Immunodeficiency
University of Calgary 1
Testing effectiveness (Phase 2)Study completedNCT02758223
What this trial is testing

Prophylactic Application of Donor-derived TCM After Allogeneic HSCT

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Wuerzburg University Hospital 16
Early research (Phase 1)WithdrawnNCT04737161
What this trial is testing

Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome

Who this might be right for
Acute Respiratory Distress SyndromeCovid19
Stanford University
Testing effectiveness (Phase 2)Looking for participantsNCT02048332
What this trial is testing

Donor-Derived Viral Specific T-cells (VSTs)

Who this might be right for
Allogeneic Stem Cell TransplantViral InfectionViral Reactivation
Children's Hospital Medical Center, Cincinnati 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT04230356
What this trial is testing

Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant

Who this might be right for
Allogeneic Stell Cell TransplantViral Infection
Children's Hospital Medical Center, Cincinnati 180
Testing effectiveness (Phase 2)Study completedNCT03883906
What this trial is testing

Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cell Transplant

Who this might be right for
Allogeneic Stem Cell TransplantViral Infection
Children's Hospital Medical Center, Cincinnati 30
Early research (Phase 1)UnknownNCT02779439
What this trial is testing

Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation

Who this might be right for
CMV InfectionEBVAdenovirus
University of Sydney 25
Not applicableNo Longer AvailableNCT03010332
What this trial is testing

Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease

Who this might be right for
CMV ViremiaCMV Disease
Atara Biotherapeutics
Large-scale testing (Phase 3)Looking for participantsNCT07225972
What this trial is testing

Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone

Who this might be right for
CMVAdV InfectionAdV Reactivation+2 more
New York Medical College 138
Post-approval studies (Phase 4)UnknownNCT05799716
What this trial is testing

Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections

Who this might be right for
ViremiaBacteremiaAcute Rejection of Renal Transplant
Shanghai Changzheng Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02136797
What this trial is testing

Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
CMV InfectionPersistent CMV Viremia
Memorial Sloan Kettering Cancer Center 77
Testing effectiveness (Phase 2)Looking for participantsNCT02007356
What this trial is testing

Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

Who this might be right for
Adenovirus InfectionEBVCytomegalovirus Infections+2 more
University Hospital, Basel, Switzerland 30
Early research (Phase 1)UnknownNCT02895412
What this trial is testing

Infection and Tumour Antigen Cellular Therapy

Who this might be right for
Leukemia, Myelocytic, Acute
University of Sydney 20
Early research (Phase 1)Looking for participantsNCT06326008
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical Trial

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in Relapse
Beijing GoBroad Hospital 48
Next Page